The Home of the Life Sciences Industry

Explore Latest News

Weeks After $74 Billion Acquisition, Celgene Strikes Two Cancer Deals

Ahead of being absorbed by Bristol-Myers Squibb, Celgene forged a strategic collaboration with two companies to develop immuno-oncology treatments and cell therapies.
Jonathan Weiss / Shutterstock.com

What’s Next? Eli Lilly’s Lartruvo Flunks Sarcoma Trial

Eli Lilly’s ANNOUNCE Phase III clinical trial of Lartruvo (olaratumab) in advanced or metastatic soft tissue sarcoma failed to meet the primary endpoints of overall survival.

Get personalized job alerts

Create a job alert and receive custom job recommendations straight to your inbox.

Employers

Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.

Post Jobs Now